BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...

Open now and remaining in situ until June, Anya's Dive Shop kicks off the spring/summer season with a celebration of underwater escapism. From the brightly painted exterior and XL shark sculpture ...

NEW YORK (AP) — U.S. stocks dove Tuesday following another stunning reversal, with Wall Street veering from a huge gain at the opening of trading to more losses at the close, because investors ...

View directly on Instagram This is truly impressive! While there may not be a category for the longest underwater dive by a dog, Fabbe might win the world record if there was! But he isn’t doing it ...

AdvaMed and nine other healthcare organizations have continued to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s ongoing tariff saga. AdvaMed, ...

A group of UnitedHealth shareholders have pulled a plan to require the massive insurance company to analyze the impact of healthcare delays and denials after UnitedHealth challenged the proposal ...

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis of Alzheimer's disease. The immunoassay measures the ratio of ptau-217 and beta amyloid 42, two distinct ...

The median funding round involving one of the roughly two dozen venture firms tracked by BioPharma Dive was worth $93 million during the first three months of 2025, according to BioPharma Dive data.

Ulysse Nardin has debuted the world’s lightest mechanical dive watch at Watches and Wonders. The Ulysse Nardin Diver [Air] has a skeletonised dial and has had its weight cut in half by removing ...

Billion-dollar biotech buyouts have become rarer. Only six of the acquisitions tracked by BioPharma Dive since July have met that mark, compared to 24 deals in the preceding nine-month period.

Citing the Times’ reporting, the senators said some organ procurement organizations of bypassing patients who have been waiting to receive organs at times for years in order to reduce their ...

Connect Biopharma (CNTB) announced the online publication of results from the global Phase 2 trial of rademikibart in patients with moderate-to-severe uncontrolled asthma in the American Journal ...